Fig. 1.

Kaplan-Meier survival curves showing first liver-related events during the Pandemic period in people with compensated NAFLD cirrhosis without prior decompensations (n = 271).

(A) By type 2 diabetes status (log-rank test = 0.08); (B) albumin serum levels ≥4 (log-rank test <0.001); and (C) FIB-4 score ≥2.67 (log-rank test <0.01). The equality of survivor functions was tested with the log-rank test and a p <0.05 was considered statistically significant. FIB-4, Fibrosis-4; NAFLD, non-alcoholic fatty liver disease.